-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.00946.51% Upside
Processa Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Processa Pharmaceuticals, Inc.?
Processa Pharmaceuticals, Inc. has been rated by research analysts at Maxim Group in the past 90 days.